ITOLIZUMAB

UNII:	XQQ2RHV14N
Formula:
Preferred Substance Name:	ITOLIZUMAB

1116433-11-4
BMAB-600
EQ001
EQ-001
IMMUNOGLOBULIN G1, ANTI-(HUMAN ANTIGEN CD6) (HUMAN-MOUSE MONOCLONAL T1H HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL T1H LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CD6 (TP120, T12)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-449) (HUMANIZED VH (HOMO SAPIENS IGHV3-21*08 (83.70%) -(IGHD)-IGHJ5*01) (8.8.12) (1-119)-HOMO SAPIENS IGHG1*01 (120-449)), (222-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-17*01 (76.80%)-IGKJ2*01 F118>L, Q120>S) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')); (228-228:231-231)-BISDISULFIDE DIMER
ITOLIZUMAB [INN]
ITOLIZUMAB [USAN]
ITOLIZUMAB [WHO-DD]
T1H

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ITOLIZUMAB

Synonyms and Mappings

Resources